Literature DB >> 26325559

Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage.

Alessandro Biffi1, Christopher D Anderson1, Thomas W K Battey1, Alison M Ayres2, Steven M Greenberg3, Anand Viswanathan3, Jonathan Rosand1.   

Abstract

IMPORTANCE: Intracerebral hemorrhage (ICH) is the most severe form of stroke. Survivors are at high risk of recurrence, death, and worsening functional disability.
OBJECTIVE: To investigate the association between blood pressure (BP) after index ICH and risk of recurrent ICH. DESIGN, SETTING, AND PARTICIPANTS: Single-site, tertiary care referral center observational study of 1145 of 2197 consecutive patients with ICH presenting from July 1994 to December 2013. A total of 1145 patients with ICH survived at least 90 days and were followed up through December 2013 (median follow-up of 36.8 months [minimum, 9.8 months]). EXPOSURES: Blood pressure measurements at 3, 6, 9, and 12 months, and every 6 months thereafter, obtained from medical personnel (inpatient hospital or outpatient clinic medical or nursing staff) or via patient self-report. Exposure was characterized in 3 ways: (1) recorded systolic and diastolic measurements; (2) classification as adequate or inadequate BP control based on American Heart Association/American Stroke Association recommendations; and (3) stage of hypertension based on Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 7 criteria. MAIN OUTCOMES AND MEASURES: Recurrent ICH and its location within the brain (lobar vs nonlobar).
RESULTS: There were 102 recurrent ICH events among 505 survivors of lobar ICH and 44 recurrent ICH events among 640 survivors of nonlobar ICH. During follow-up adequate BP control was achieved on at least 1 measurement by 625 patients (54.6% of total [range, 49.2%-58.7%]) and consistently (ie, at all available time points) by 495 patients (43.2% of total [range, 34.5%-51.0%]). The event rate for lobar ICH was 84 per 1000 person-years among patients with inadequate BP control compared with 49 per 1000 person-years among patients with adequate BP control. For nonlobar ICH the event rate was 52 per 1000 person-years with inadequate BP control compared with 27 per 1000 person-years for patients with adequate BP control. In analyses modeling BP control as a time-varying variable, inadequate BP control was associated with higher risk of recurrence of both lobar ICH (hazard ratio [HR], 3.53 [95% CI, 1.65-7.54]) and nonlobar ICH (HR, 4.23 [95% CI, 1.02-17.52]). Systolic BP during follow-up was associated with increased risk of both lobar ICH recurrence (HR, 1.33 per 10-mm Hg increase [95% CI, 1.02-1.76]) and nonlobar ICH recurrence (HR, 1.54 [95% CI, 1.03-2.30]). Diastolic BP was associated with increased risk of nonlobar ICH recurrence (HR, 1.21 per 10-mm Hg increase [95% CI, 1.01-1.47]) but not with lobar ICH recurrence (HR, 1.36 [95% CI, 0.90-2.10]). CONCLUSIONS AND RELEVANCE: In this observational single-center cohort study of ICH survivors, reported BP measurements suggesting inadequate BP control during follow-up were associated with higher risk of both lobar and nonlobar ICH recurrence. These data suggest that randomized clinical trials are needed to address the benefits and risks of stricter BP control in ICH survivors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26325559      PMCID: PMC4737594          DOI: 10.1001/jama.2015.10082

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  19 in total

1.  Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996.

Authors:  M L Eigenbrodt; K M Rose; D J Couper; D K Arnett; R Smith; D Jones
Journal:  Stroke       Date:  2000-10       Impact factor: 7.914

2.  Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial.

Authors:  Hisatomi Arima; John Chalmers; Mark Woodward; Craig Anderson; Anthony Rodgers; Stephen Davis; Stephen Macmahon; Bruce Neal
Journal:  J Hypertens       Date:  2006-06       Impact factor: 4.844

3.  Cost-effectiveness of hypertension therapy according to 2014 guidelines.

Authors:  Andrew E Moran; Michelle C Odden; Anusorn Thanataveerat; Keane Y Tzong; Petra W Rasmussen; David Guzman; Lawrence Williams; Kirsten Bibbins-Domingo; Pamela G Coxson; Lee Goldman
Journal:  N Engl J Med       Date:  2015-01-29       Impact factor: 91.245

4.  Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy.

Authors:  A Biffi; A Halpin; A Towfighi; A Gilson; K Busl; N Rost; E E Smith; M S Greenberg; J Rosand; A Viswanathan
Journal:  Neurology       Date:  2010-08-24       Impact factor: 9.910

Review 5.  Intracerebral hemorrhage.

Authors:  Neeraj Badjatia; Jonathan Rosand
Journal:  Neurologist       Date:  2005-11       Impact factor: 1.398

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 7.  Blood pressure control in the elderly: can you have too much of a good thing?

Authors:  David J Hyman; George E Taffet
Journal:  Curr Hypertens Rep       Date:  2009-10       Impact factor: 5.369

8.  Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial.

Authors:  Hisatomi Arima; Christophe Tzourio; Craig Anderson; Mark Woodward; Marie-Germaine Bousser; Stephen MacMahon; Bruce Neal; John Chalmers
Journal:  Stroke       Date:  2009-12-31       Impact factor: 7.914

9.  Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial.

Authors:  Hisatomi Arima; Craig Anderson; Teruo Omae; Mark Woodward; Stephen MacMahon; Giuseppe Mancia; Marie-Germaine Bousser; Christophe Tzourio; Stephen Harrap; Lisheng Liu; Bruce Neal; John Chalmers
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-05-14       Impact factor: 10.154

10.  Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group.

Authors:  Joseph Broderick; Sander Connolly; Edward Feldmann; Daniel Hanley; Carlos Kase; Derk Krieger; Marc Mayberg; Lewis Morgenstern; Christopher S Ogilvy; Paul Vespa; Mario Zuccarello
Journal:  Circulation       Date:  2007-10-16       Impact factor: 29.690

View more
  69 in total

1.  Sex differences in intracerebral hemorrhage expansion and mortality.

Authors:  Sandro Marini; Andrea Morotti; Alison M Ayres; Katherine Crawford; Christina E Kourkoulis; Umme K Lena; Edip M Gurol; Anand Viswanathan; Joshua N Goldstein; Steven M Greenberg; Alessandro Biffi; Jonathan Rosand; Christopher D Anderson
Journal:  J Neurol Sci       Date:  2017-05-31       Impact factor: 3.181

2.  One-Year Rates and Determinants of Poststroke Systolic Blood Pressure Control among Ghanaians.

Authors:  Fred Stephen Sarfo; Gloria Kyem; Bruce Ovbiagele; John Akassi; Osei Sarfo-Kantanka; Martin Agyei; Elizabeth Badu; Nathaniel Adusei Mensah
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-09-14       Impact factor: 2.136

3.  Blood Pressure Management in Intracranial Hemorrhage: Current Challenges and Opportunities.

Authors:  Cheryl Carcel; Shoichiro Sato; Craig S Anderson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-04

Review 4.  [Ability to drive with cerebrovascular diseases : Position paper of the German societies DGNB, DGN, DGNC, DGNR, DSG and GNP].

Authors:  P Marx; G F Hamann; O Busse; T Mokrusch; H Niemann; H Vatter; B Widder
Journal:  Nervenarzt       Date:  2019-04       Impact factor: 1.214

Review 5.  Emerging concepts in sporadic cerebral amyloid angiopathy.

Authors:  Andreas Charidimou; Gregoire Boulouis; M Edip Gurol; Cenk Ayata; Brian J Bacskai; Matthew P Frosch; Anand Viswanathan; Steven M Greenberg
Journal:  Brain       Date:  2017-07-01       Impact factor: 13.501

6.  Management of acute intracerebral haemorrhage - an update.

Authors:  Zhe Kang Law; Jason P Appleton; Philip M Bath; Nikola Sprigg
Journal:  Clin Med (Lond)       Date:  2017-04       Impact factor: 2.659

7.  Blood Pressure Management After Intracerebral Hemorrhage.

Authors:  Shoichiro Sato; Cheryl Carcel; Craig S Anderson
Journal:  Curr Treat Options Neurol       Date:  2015-12       Impact factor: 3.598

Review 8.  Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation.

Authors:  Eleni Korompoki; Filippos T Filippidis; Peter B Nielsen; Angela Del Giudice; Gregory Y H Lip; Joji B Kuramatsu; Hagen B Huttner; Jiming Fang; Sam Schulman; Joan Martí-Fàbregas; Celine S Gathier; Anand Viswanathan; Alessandro Biffi; Daniela Poli; Christian Weimar; Uwe Malzahn; Peter Heuschmann; Roland Veltkamp
Journal:  Neurology       Date:  2017-07-19       Impact factor: 9.910

9.  Cortical superficial siderosis progression in cerebral amyloid angiopathy: Prospective MRI study.

Authors:  Thanakit Pongpitakmetha; Panagiotis Fotiadis; Marco Pasi; Gregoire Boulouis; Li Xiong; Andrew D Warren; Kristin M Schwab; Jonathan Rosand; M Edip Gurol; Steven M Greenberg; Anand Viswanathan; Andreas Charidimou
Journal:  Neurology       Date:  2020-04-13       Impact factor: 9.910

10.  Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage.

Authors:  Meredith P Murphy; Joji B Kuramatsu; Audrey Leasure; Guido J Falcone; Hooman Kamel; Lauren H Sansing; Christina Kourkoulis; Kristin Schwab; Jordan J Elm; M Edip Gurol; Huy Tran; Steven M Greenberg; Anand Viswanathan; Christopher D Anderson; Stefan Schwab; Jonathan Rosand; Fu-Dong Shi; Steven J Kittner; Fernando D Testai; Daniel Woo; Carl D Langefeld; Michael L James; Sebastian Koch; Hagen B Huttner; Alessandro Biffi; Kevin N Sheth
Journal:  Stroke       Date:  2018-11       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.